Skin health should be measurable, objective, and grounded in data

Today, we’re sharing an update on how we’re continuing to build around a simple idea: skin health should be measurable, objective, and grounded in data — reflected in our newly rebranded website.

Our platform is built on non-invasive chromophore imaging, enabling real-time visualization and analysis of key skin biomarkers — collagen, melanin, and hemoglobin.

Most approaches rely on what can be seen on the surface. MedX focuses on what’s happening beneath it, capturing subsurface biological signals and making them measurable and trackable over time.

Today, the platform is supported by:

• ~85,000 clinically reviewed subsurface images

• 14+ peer-reviewed validations

• Deployment across 37 global territories

• Regulatory compliance across FDA, ISO, CE, HIPAA, and MDSAP

While teledermatology remains an important application, this technology is also being used in clinical research, CRO-led trials, and broader skin health initiatives.

Watch the full announcement: https://youtu.be/hs42vRJCHjw